Literature DB >> 25424328

Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes.

Shuta Motonishi1, Masaomi Nangaku2, Takehiko Wada1, Yu Ishimoto1, Takamoto Ohse1, Taiji Matsusaka3, Naoto Kubota4, Akira Shimizu5, Takashi Kadowaki4, Kazuyuki Tobe6, Reiko Inagi7.   

Abstract

Recent studies have highlighted the renoprotective effect of sirtuin1 (SIRT1), a deacetylase that contributes to cellular regulation. However, the pathophysiologic role of SIRT1 in podocytes remains unclear. Here, we investigated the function of SIRT1 in podocytes. We first established podocyte-specific Sirt1 knockout (SIRT1(pod-/-)) mice. We then induced glomerular disease by nephrotoxic serum injection. The increase in urinary albumin excretion and BUN and the severity of glomerular injury were all significantly greater in SIRT1(pod-/-) mice than in wild-type mice. Western blot analysis and immunofluorescence showed a significant decrease in podocyte-specific proteins in SIRT1(pod-/-) mice, and electron microscopy showed marked exacerbation of podocyte injury, including actin cytoskeleton derangement in SIRT1(pod-/-) mice compared with wild-type mice. Protamine sulfate-induced podocyte injury was also exacerbated by podocyte-specific SIRT1 deficiency. In vitro, actin cytoskeleton derangement in H2O2-treated podocytes became prominent when the cells were pretreated with SIRT1 inhibitors. Conversely, this H2O2-induced derangement was ameliorated by SIRT1 activation. Furthermore, SIRT1 activation deacetylated the actin-binding and -polymerizing protein cortactin in the nucleus and facilitated deacetylated cortactin localization in the cytoplasm. Cortactin knockdown or inhibition of the nuclear export of cortactin induced actin cytoskeleton derangement and dissociation of cortactin from F-actin, suggesting the necessity of cytoplasmic cortactin for maintenance of the actin cytoskeleton. Taken together, these findings indicate that SIRT1 protects podocytes and prevents glomerular injury by deacetylating cortactin and thereby, maintaining actin cytoskeleton integrity.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  SIRT1; cortactin; cytoskeleton; podocyte

Mesh:

Substances:

Year:  2014        PMID: 25424328      PMCID: PMC4520160          DOI: 10.1681/ASN.2014030289

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  69 in total

1.  Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.

Authors:  Yanggang Yuan; Songming Huang; Wenyan Wang; Yingying Wang; Ping Zhang; Chunhua Zhu; Guixia Ding; Bicheng Liu; Tianxin Yang; Aihua Zhang
Journal:  Kidney Int       Date:  2012-05-30       Impact factor: 10.612

2.  Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

Authors:  Shinji Kume; Takashi Uzu; Kihachiro Horiike; Masami Chin-Kanasaki; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 3.  Sirtuins and their relevance to the kidney.

Authors:  Chuan-Ming Hao; Volker H Haase
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

4.  Sirt1 activation protects the mouse renal medulla from oxidative injury.

Authors:  Wenjuan He; Yingying Wang; Ming-Zhi Zhang; Li You; Linda S Davis; Hong Fan; Hai-Chun Yang; Agnes B Fogo; Roy Zent; Raymond C Harris; Matthew D Breyer; Chuan-Ming Hao
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

5.  SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.

Authors:  Yu Jin Jung; Jung Eun Lee; Ae Sin Lee; Kyung Pyo Kang; Sik Lee; Sung Kwang Park; Sang Yong Lee; Myung Kwan Han; Duk Hoon Kim; Won Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-02-05       Impact factor: 3.575

6.  Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function.

Authors:  Kazuhiro Hasegawa; Shu Wakino; Kyoko Yoshioka; Satoru Tatematsu; Yoshikazu Hara; Hitoshi Minakuchi; Keiko Sueyasu; Naoki Washida; Hirobumi Tokuyama; Maty Tzukerman; Karl Skorecki; Koichi Hayashi; Hiroshi Itoh
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

7.  Activity-dependent redistribution and essential role of cortactin in dendritic spine morphogenesis.

Authors:  Heike Hering; Morgan Sheng
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

Review 8.  The tale of protein lysine acetylation in the cytoplasm.

Authors:  Karin Sadoul; Jin Wang; Boubou Diagouraga; Saadi Khochbin
Journal:  J Biomed Biotechnol       Date:  2010-11-28

9.  SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase.

Authors:  Ilwola Mattagajasingh; Cuk-Seong Kim; Asma Naqvi; Tohru Yamamori; Timothy A Hoffman; Saet-Byel Jung; Jeremy DeRicco; Kenji Kasuno; Kaikobad Irani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

10.  Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.

Authors:  Peter Y Chuang; Yan Dai; Ruijie Liu; Helen He; Matthias Kretzler; Belinda Jim; Clemens D Cohen; John C He
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

View more
  21 in total

Review 1.  Are podocytes motile?

Authors:  Nicole Endlich; Florian Siegerist; Karlhans Endlich
Journal:  Pflugers Arch       Date:  2017-06-24       Impact factor: 3.657

Review 2.  Podocytes from the diagnostic and therapeutic point of view.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pflugers Arch       Date:  2017-05-16       Impact factor: 3.657

3.  Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.

Authors:  Mai Sugahara; Shinji Tanaka; Tetsuhiro Tanaka; Hisako Saito; Yu Ishimoto; Takeshi Wakashima; Masatoshi Ueda; Kenji Fukui; Akira Shimizu; Reiko Inagi; Toshimasa Yamauchi; Takashi Kadowaki; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2020-01-29       Impact factor: 10.121

4.  SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation.

Authors:  Mingzhu Jiang; Min Zhao; Mi Bai; Juan Lei; Yanggang Yuan; Songming Huang; Yue Zhang; Guixia Ding; Zhanjun Jia; Aihua Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-03-10

Review 5.  Histone Deacetylases Take Center Stage on Regulation of Podocyte Function.

Authors:  Min Liu; Zhe Qiao; Yang Zhang; Ping Zhan; Fan Yi
Journal:  Kidney Dis (Basel)       Date:  2020-04-29

Review 6.  Sirtuin and metabolic kidney disease.

Authors:  Shu Wakino; Kazuhiro Hasegawa; Hiroshi Itoh
Journal:  Kidney Int       Date:  2015-06-17       Impact factor: 10.612

7.  Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.

Authors:  Min Liu; Kaili Liang; Junhui Zhen; Meng Zhou; Xiaojie Wang; Ziying Wang; Xinbing Wei; Yan Zhang; Yu Sun; Zhuanli Zhou; Hua Su; Chun Zhang; Ningjun Li; Chengjiang Gao; Jun Peng; Fan Yi
Journal:  Nat Commun       Date:  2017-09-04       Impact factor: 14.919

8.  Sirt6 deficiency results in progression of glomerular injury in the kidney.

Authors:  Wen Huang; Hua Liu; Shuang Zhu; Michael Woodson; Rong Liu; Ronald G Tilton; Jordan D Miller; Wenbo Zhang
Journal:  Aging (Albany NY)       Date:  2017-03-28       Impact factor: 5.682

Review 9.  Cortactin in cancer cell migration and invasion.

Authors:  Miao Yin; Wenqing Ma; Liguo An
Journal:  Oncotarget       Date:  2017-09-19

10.  Potential role of sirtuin 1 in Müller glial cells in mice choroidal neovascularization.

Authors:  Tomoka Ishida; Takeshi Yoshida; Kosei Shinohara; Kejia Cao; Ken-Ichi Nakahama; Ikuo Morita; Kyoko Ohno-Matsui
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.